Explore the detailed record of transactions filed by LENZ BRIAN, Chief Financial Officer. Officer active across 1 companies, notably Adma Biologics, INC.. Aggregated, 7 disclosures have been recorded. Total volume traded: €52k. The latest transaction was disclosed on 11 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Brian Lenz serves as the Executive Vice President and Chief Financial Officer of ADMA BIOLOGICS, INC. In this role, he is responsible for the financial management of the company, including financial planning and risk management. Brian brings expertise in finance and corporate strategy, contributing to the growth and sustainability of ADMA. His experience enables him to navigate the complex financial landscape and optimize the company's resources.